Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devico

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Journal of Leukocyte Biology|September 12, 2006
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variantJean K Lim, Wuyuan Lu, Oliver Hartley, et al.
Plos Pathogens|March 26, 2015
Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsMeron Mengistu, Krishanu Ray, George K Lewis, et al.
Viruses|September 23, 2015
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1George K Lewis, Andrés Finzi, Anthony L DeVico, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivityEmabelle J Ramnarine, Anthony L Devico, Sandra C Vigil-Cruz
Journal of Leukocyte Biology|June 1, 2005
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5Jean K Lim, Jennifer M Burns, Wuyuan Lu, et al.
Trends in Molecular Medicine|February 23, 2019
Broadly Neutralizing Antibodies against HIV: Back to BloodAmir Dashti, Anthony L DeVico, George K Lewis, et al.
AIDS Research and Human Retroviruses|July 22, 1998
Beta-chemokines and protection from HIV type 1 diseaseA Garzino-Demo, A L DeVico, F Cocchi, et al.
Journal of Virology|October 17, 2001
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusionC M Finnegan, W Berg, G K Lewis, et al.
Journal of Virology|November 5, 2002
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusionCatherine M Finnegan, Werner Berg, George K Lewis, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individualsA L Devico, R Rahman, M G Sarngadharan, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Journal of Leukocyte Biology|September 12, 2006
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variantJean K Lim, Wuyuan Lu, Oliver Hartley, et al.
Plos Pathogens|March 26, 2015
Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsMeron Mengistu, Krishanu Ray, George K Lewis, et al.
Viruses|September 23, 2015
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1George K Lewis, Andrés Finzi, Anthony L DeVico, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivityEmabelle J Ramnarine, Anthony L Devico, Sandra C Vigil-Cruz
Journal of Leukocyte Biology|June 1, 2005
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5Jean K Lim, Jennifer M Burns, Wuyuan Lu, et al.
Trends in Molecular Medicine|February 23, 2019
Broadly Neutralizing Antibodies against HIV: Back to BloodAmir Dashti, Anthony L DeVico, George K Lewis, et al.
AIDS Research and Human Retroviruses|July 22, 1998
Beta-chemokines and protection from HIV type 1 diseaseA Garzino-Demo, A L DeVico, F Cocchi, et al.
Journal of Virology|October 17, 2001
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusionC M Finnegan, W Berg, G K Lewis, et al.
Journal of Virology|November 5, 2002
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusionCatherine M Finnegan, Werner Berg, George K Lewis, et al.
AIDS Research and Human Retroviruses|August 1, 1994
Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individualsA L Devico, R Rahman, M G Sarngadharan, et al.
Pageof 13